Growth hormone secretagogues as diagnostic tools in disease states (Q34231673)

31 July 2017

1 reference

title

Growth hormone secretagogues as diagnostic tools in disease states (English)

1 reference

31 July 2017

R Baldelli

1

1 reference

31 July 2017

X L Otero

2

1 reference

31 July 2017

J P Camiña

3

1 reference

31 July 2017

O Gualillo

4

1 reference

31 July 2017

V Popovic

5

1 reference

31 July 2017

C Dieguez

6

1 reference

31 July 2017

F F Casanueva

7

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

14

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

95-99

1 reference

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

31 July 2017

cites work

1 reference

12 December 2020

Growth hormone-releasing peptides

1 reference

12 December 2020

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy

1 reference

12 December 2020

Influence of metabolic substrates and obesity on growth hormone secretion

1 reference

12 December 2020

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

12 December 2020

Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat.

1 reference

12 December 2020

Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults

1 reference

12 December 2020

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

12 December 2020

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

1 reference

12 December 2020

Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity

1 reference

12 December 2020

Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test

1 reference

12 December 2020

Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection

1 reference

12 December 2020

Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs

1 reference

12 December 2020

Theoretical considerations in estimating the growth hormone axis in adults.

1 reference

12 December 2020

Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hyp

1 reference

12 December 2020

Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone

1 reference

12 December 2020

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

1 reference

12 December 2020

An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year

1 reference

12 December 2020

Mechanisms of T-cell Apoptosis Induced by Glucocorticoids

1 reference

12 December 2020

Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6

1 reference

12 December 2020

Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome

1 reference

12 December 2020

The assessment of growth hormone status in normal young adult males using a variety of provocative agents

1 reference

12 December 2020

Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues

1 reference

12 December 2020

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

12 December 2020

Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.

1 reference

12 December 2020

On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone

1 reference

12 December 2020

Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH-releasing hexapeptide-6.

1 reference

12 December 2020

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

1 reference

12 December 2020

Growth Hormone Secretagogues: Physiological Role and Clinical Utility

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:14:1:095

1 reference

Dimensions Publication ID

31 July 2017

1052991422

0 references

1 reference